CS
SYNH

Candriam SCA’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Candriam SCA’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,373
Closed -$438K – 893
2023
Q1 		$438K Buy
+13,373
New +$485K ﹤0.01% 795

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Candriam SCA's SYNH Position: Q2 2023 in Review

Candriam SCA sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 13,373 shares — an estimated $438K sold.

Candriam SCA first reported a position in SYNH in Q1 2023 and held it in 1 quarter. The position peaked at $438K in Q1 2023. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Candriam SCA reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 13,373 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $438K.
  • Candriam SCA first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2023 and held it in 1 quarter.
  • Candriam SCA's Syneos Health, Inc. Class A Common Stock position peaked at $438K in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.